BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9771693)

  • 41. Concomitant Epstein-Barr virus (EBV)-positive B-cell and EBV-negative T-cell posttransplant lymphoproliferative disorders after renal allografting: pathogenetic implications.
    Au WY; Lam MF; Pang A; Leung RY; Kwong YL
    Transplantation; 2011 Dec; 92(12):e67-8. PubMed ID: 22158471
    [No Abstract]   [Full Text] [Related]  

  • 42. The dual-function CD150 receptor subfamily: the viral attraction.
    Sidorenko SP; Clark EA
    Nat Immunol; 2003 Jan; 4(1):19-24. PubMed ID: 12496974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.
    Ando I; Morgan G; Levinsky RJ; Crawford DH
    Clin Exp Immunol; 1986 Feb; 63(2):271-9. PubMed ID: 3009060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
    Rustgi VK
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient.
    Taguchi Y; Purtilo DT; Okano M
    Transplantation; 1994 Jun; 57(12):1813-5. PubMed ID: 8016889
    [No Abstract]   [Full Text] [Related]  

  • 46. [X-linked lymphoproliferative syndrome].
    Kanegane H
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):129-34. PubMed ID: 11963172
    [No Abstract]   [Full Text] [Related]  

  • 47. X-linked lymphoproliferative disease.
    Seemayer TA; Grierson H; Pirruccello SJ; Gross TG; Weisenburger DD; Davis J; Spiegel K; Brichacek B; Sumegi J
    Am J Dis Child; 1993 Nov; 147(11):1242-5. PubMed ID: 8237920
    [No Abstract]   [Full Text] [Related]  

  • 48. Virus-induced lymphomas in transplant patients under immunosuppressive therapy.
    Touraine JL; Deteix P; el Yafi M; Traeger J; Dubernard JM; LeFrancois N; Lenoir G; de Thé G
    Transplant Proc; 1987 Oct; 19(5):4087-8. PubMed ID: 2823437
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome.
    Risitano AM; Camera A; Chiurazzi F; Rossi M; D'Arco AM; Rotoli B
    Haematologica; 2002 Aug; 87(8):ELT36. PubMed ID: 12161381
    [No Abstract]   [Full Text] [Related]  

  • 50. Bone marrow transplantation during fulminant EBV-infection in Duncan's syndrome.
    Pracher E; Grümayer-Panzer ER; Zoubek A; Peters C; Gadner H
    Lancet; 1993 Nov; 342(8883):1362. PubMed ID: 7901651
    [No Abstract]   [Full Text] [Related]  

  • 51. Metachronous B-cell and T-cell post-transplant lymphoproliferative disorders with features of chronic active Epstein-Barr virus infection.
    Liu ID; Tan PL; Tan CX; Isa MS; Lau PY; Yeo WS; Chaturvedi S; Villegas MS; Ng KH; Yap HK; Ng SB
    Am J Hematol; 2015 Oct; 90(10):E204-5. PubMed ID: 26178917
    [No Abstract]   [Full Text] [Related]  

  • 52. Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplantation; 1995 Feb; 59(4):637-40. PubMed ID: 7533350
    [No Abstract]   [Full Text] [Related]  

  • 53. Bone marrow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis.
    Imashuku S; Naya M; Yamori M; Nakabayashi Y; Hojo M; Kihara A; Tabata Y; Akioka C; Hibi S; Todo S
    Bone Marrow Transplant; 1997 May; 19(10):1059-60. PubMed ID: 9169655
    [No Abstract]   [Full Text] [Related]  

  • 54. Cytotoxic T cells and immunotherapy.
    Kitchingman GR; Rooney C
    Pediatr Radiol; 1998 Jul; 28(7):489-91. PubMed ID: 9662564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B cell memory: sapping the T cell.
    Welsh RM; Stepp SE; Szomolanyi-Tsuda E
    Nat Med; 2003 Feb; 9(2):164-6. PubMed ID: 12563333
    [No Abstract]   [Full Text] [Related]  

  • 56. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 57. B cells and herpesviruses: a model of lymphoproliferation.
    Barozzi P; Potenza L; Riva G; Vallerini D; Quadrelli C; Bosco R; Forghieri F; Torelli G; Luppi M
    Autoimmun Rev; 2007 Dec; 7(2):132-6. PubMed ID: 18035323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions between viral and human genes.
    Griffiths PD
    Rev Med Virol; 2002; 12(4):197-9. PubMed ID: 12125011
    [No Abstract]   [Full Text] [Related]  

  • 59. Post-transplantation lymphoproliferative disease. Introduction.
    Klein G
    Springer Semin Immunopathol; 1998; 20(3-4):319-23. PubMed ID: 9870248
    [No Abstract]   [Full Text] [Related]  

  • 60. Limbic encephalitis as presentation of a SAP deficiency.
    Verhelst H; Van Coster R; Bockaert N; Laureys G; Latour S; Fischer A; Haerynck F
    Neurology; 2007 Jul; 69(2):218-9. PubMed ID: 17620557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.